0.2249
12.68%
+0.0253
Pre-mercato:
.23
0.0051
+2.27%
Cns Pharmaceuticals Inc Azioni (CNSP) Dati Finanziari
Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 |
Durata del periodo | 3 mesi | 3 mesi | 3 mesi | 3 mesi | 3 mesi |
Revenues |
-
|
- | - | - | - |
Operating Expenses
|
12.63%
4.5338
|
4.0254 | 4.9265 | 5.502 | 3.419 |
Interest Income/Expense |
49.64%
0.00184
|
0.00365 | 0.00544 | 0.00231 | 0.000538 |
Operating Income/Loss |
12.63%
-4.5338
|
-4.0254 | -4.9265 | -5.502 | -3.419 |
Nonoperating Income/Loss |
166.02%
0.011
|
0.00415 | -0.00544 | -0.00231 | -0.000538 |
Income/Loss From Continuing Operations Before Tax |
12.47%
-4.5228
|
-4.0212 | -4.9319 | -5.5043 | -3.4196 |
Income/Loss From Continuing Operations After Tax |
12.47%
-4.5228
|
-4.0212 | -4.9319 | -5.5043 | -3.4196 |
Net Income/Loss
|
12.47%
-4.5228
|
-4.0212 | -4.9319 | -5.5043 | -3.4196 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
7.73%
4.1771
|
3.8773 | 1.9065 | -38.27 | 40.03 |
Diluted Average Shares |
7.73%
4.1771
|
3.8773 | 1.9065 | -38.27 | 40.03 |
Basic Earnings Per Share |
3.85%
-1.08
|
-1.04 | -2.59 | -10.97 | -0.09 |
Diluted Earnings Per Share |
3.85%
-1.08
|
-1.04 | -2.59 | -10.97 | -0.09 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
Capitalizzazione:
|
Volume (24 ore):